Rankings
▼
Calendar
PLSE Q3 2025 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
PLSE
Pulse Biosciences, Inc.
$1B
Q3 2025 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$86,000
Gross Profit
-$193,000
-224.4% margin
Operating Income
-$20M
-23682.6% margin
Net Income
-$19M
-22540.7% margin
EPS (Diluted)
$-0.29
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$109M
Total Liabilities
$16M
Stockholders' Equity
$93M
Cash & Equivalents
$95M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$86,000
$0
—
Gross Profit
-$193,000
$0
—
Operating Income
-$20M
-$14M
-49.2%
Net Income
-$19M
-$13M
-52.9%
Revenue Segments
Operating Segments
$172,000
100%
← FY 2025
All Quarters
Q4 2025 →